nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—Epinephrine—Dipivefrin—glaucoma	0.152	0.427	CrCrCtD
Norepinephrine—Salbutamol—Carteolol—glaucoma	0.102	0.286	CrCrCtD
Norepinephrine—Salbutamol—Levobunolol—glaucoma	0.102	0.286	CrCrCtD
Norepinephrine—ADRB2—Metipranolol—glaucoma	0.0259	0.0485	CbGbCtD
Norepinephrine—ADRB2—Levobunolol—glaucoma	0.0259	0.0485	CbGbCtD
Norepinephrine—ADRB1—Levobunolol—glaucoma	0.0255	0.0478	CbGbCtD
Norepinephrine—ADRB1—Metipranolol—glaucoma	0.0255	0.0478	CbGbCtD
Norepinephrine—ADRB3—Timolol—glaucoma	0.0234	0.0439	CbGbCtD
Norepinephrine—ADRA2C—Brimonidine—glaucoma	0.0224	0.042	CbGbCtD
Norepinephrine—ADRA2C—Apraclonidine—glaucoma	0.0224	0.042	CbGbCtD
Norepinephrine—ADRB2—Carteolol—glaucoma	0.022	0.0413	CbGbCtD
Norepinephrine—ADRB1—Carteolol—glaucoma	0.0217	0.0406	CbGbCtD
Norepinephrine—ADRA2B—Brimonidine—glaucoma	0.0213	0.0399	CbGbCtD
Norepinephrine—ADRA2B—Apraclonidine—glaucoma	0.0213	0.0399	CbGbCtD
Norepinephrine—SLC22A1—Latanoprost—glaucoma	0.0191	0.0358	CbGbCtD
Norepinephrine—ADRA2C—Dipivefrin—glaucoma	0.0179	0.0336	CbGbCtD
Norepinephrine—ADRA2B—Dipivefrin—glaucoma	0.017	0.0319	CbGbCtD
Norepinephrine—ADRB2—Dipivefrin—glaucoma	0.0157	0.0294	CbGbCtD
Norepinephrine—ADRB2—Betaxolol—glaucoma	0.0149	0.0279	CbGbCtD
Norepinephrine—ADRA2A—Brimonidine—glaucoma	0.0148	0.0277	CbGbCtD
Norepinephrine—ADRA2A—Apraclonidine—glaucoma	0.0148	0.0277	CbGbCtD
Norepinephrine—ADRB1—Betaxolol—glaucoma	0.0146	0.0274	CbGbCtD
Norepinephrine—ADRA1A—Apraclonidine—glaucoma	0.0142	0.0266	CbGbCtD
Norepinephrine—SLC22A3—Clonidine—glaucoma	0.0138	0.0258	CbGbCtD
Norepinephrine—ADRA2A—Dipivefrin—glaucoma	0.0118	0.0222	CbGbCtD
Norepinephrine—ADRA1A—Dipivefrin—glaucoma	0.0113	0.0213	CbGbCtD
Norepinephrine—ADRA1D—Clonidine—glaucoma	0.0102	0.0192	CbGbCtD
Norepinephrine—ADRB2—Timolol—glaucoma	0.00958	0.018	CbGbCtD
Norepinephrine—ADRB1—Timolol—glaucoma	0.00943	0.0177	CbGbCtD
Norepinephrine—ADRA2C—Clonidine—glaucoma	0.00931	0.0175	CbGbCtD
Norepinephrine—ADRA2B—Clonidine—glaucoma	0.00883	0.0166	CbGbCtD
Norepinephrine—SLC22A5—Clonidine—glaucoma	0.00854	0.016	CbGbCtD
Norepinephrine—ADRA1B—Clonidine—glaucoma	0.00746	0.014	CbGbCtD
Norepinephrine—SLC22A1—Clonidine—glaucoma	0.00707	0.0133	CbGbCtD
Norepinephrine—SLC6A2—Clonidine—glaucoma	0.00681	0.0128	CbGbCtD
Norepinephrine—ADRA2A—Clonidine—glaucoma	0.00614	0.0115	CbGbCtD
Norepinephrine—ADRA1A—Clonidine—glaucoma	0.00589	0.011	CbGbCtD
Norepinephrine—CYP1A2—Betaxolol—glaucoma	0.00452	0.00848	CbGbCtD
Norepinephrine—CYP1A2—Clonidine—glaucoma	0.00248	0.00465	CbGbCtD
Norepinephrine—Bradycardia—Physostigmine—glaucoma	0.00178	0.0296	CcSEcCtD
Norepinephrine—Extravasation—Carbachol—glaucoma	0.00169	0.0282	CcSEcCtD
Norepinephrine—Photophobia—Metipranolol—glaucoma	0.00156	0.026	CcSEcCtD
Norepinephrine—Photophobia—Carteolol—glaucoma	0.00145	0.0241	CcSEcCtD
Norepinephrine—Arrhythmia—Dipivefrin—glaucoma	0.00133	0.0221	CcSEcCtD
Norepinephrine—Pallor—Apraclonidine—glaucoma	0.0013	0.0217	CcSEcCtD
Norepinephrine—Photophobia—Latanoprost—glaucoma	0.00127	0.0211	CcSEcCtD
Norepinephrine—ADRB2—Treprostinil—Latanoprost—glaucoma	0.00112	1	CbGdCrCtD
Norepinephrine—Pallor—Brimonidine—glaucoma	0.00112	0.0186	CcSEcCtD
Norepinephrine—Hypertension—Dipivefrin—glaucoma	0.00112	0.0186	CcSEcCtD
Norepinephrine—Photophobia—Apraclonidine—glaucoma	0.00101	0.0169	CcSEcCtD
Norepinephrine—Photophobia—Bimatoprost—glaucoma	0.000982	0.0164	CcSEcCtD
Norepinephrine—Blood pressure increased—Travoprost—glaucoma	0.000881	0.0147	CcSEcCtD
Norepinephrine—Blood pressure increased—Brinzolamide—glaucoma	0.000869	0.0145	CcSEcCtD
Norepinephrine—Photophobia—Brimonidine—glaucoma	0.000869	0.0145	CcSEcCtD
Norepinephrine—Bradycardia—Metipranolol—glaucoma	0.00085	0.0142	CcSEcCtD
Norepinephrine—Photophobia—Dorzolamide—glaucoma	0.00083	0.0138	CcSEcCtD
Norepinephrine—Photophobia—Travoprost—glaucoma	0.000827	0.0138	CcSEcCtD
Norepinephrine—Photophobia—Brinzolamide—glaucoma	0.000816	0.0136	CcSEcCtD
Norepinephrine—Pallor—Clonidine—glaucoma	0.000805	0.0134	CcSEcCtD
Norepinephrine—Sweating—Carbachol—glaucoma	0.000792	0.0132	CcSEcCtD
Norepinephrine—Vomiting—Physostigmine—glaucoma	0.000789	0.0131	CcSEcCtD
Norepinephrine—Bradycardia—Carteolol—glaucoma	0.000787	0.0131	CcSEcCtD
Norepinephrine—Aggression—Clonidine—glaucoma	0.00076	0.0127	CcSEcCtD
Norepinephrine—Bradycardia—Levobunolol—glaucoma	0.000744	0.0124	CcSEcCtD
Norepinephrine—Arrhythmia—Carteolol—glaucoma	0.000691	0.0115	CcSEcCtD
Norepinephrine—Arrhythmia—Carbachol—glaucoma	0.000663	0.011	CcSEcCtD
Norepinephrine—Arrhythmia—Levobunolol—glaucoma	0.000653	0.0109	CcSEcCtD
Norepinephrine—Hypertension—Metipranolol—glaucoma	0.000627	0.0105	CcSEcCtD
Norepinephrine—Anxiety—Metipranolol—glaucoma	0.000616	0.0103	CcSEcCtD
Norepinephrine—Bradycardia—Apraclonidine—glaucoma	0.000551	0.00919	CcSEcCtD
Norepinephrine—Photophobia—Betaxolol—glaucoma	0.000545	0.00909	CcSEcCtD
Norepinephrine—Chest pain—Levobunolol—glaucoma	0.000542	0.00902	CcSEcCtD
Norepinephrine—Dyspnoea—Metipranolol—glaucoma	0.000529	0.00881	CcSEcCtD
Norepinephrine—Hyperhidrosis—Carbachol—glaucoma	0.00051	0.00849	CcSEcCtD
Norepinephrine—Chest pain—Latanoprost—glaucoma	0.000502	0.00837	CcSEcCtD
Norepinephrine—Dyspnoea—Carteolol—glaucoma	0.00049	0.00816	CcSEcCtD
Norepinephrine—Arrhythmia—Apraclonidine—glaucoma	0.000484	0.00806	CcSEcCtD
Norepinephrine—Blood pressure increased—Timolol—glaucoma	0.000475	0.00791	CcSEcCtD
Norepinephrine—Sweating—Dorzolamide—glaucoma	0.000474	0.0079	CcSEcCtD
Norepinephrine—Bradycardia—Brimonidine—glaucoma	0.000473	0.00789	CcSEcCtD
Norepinephrine—Dyspnoea—Levobunolol—glaucoma	0.000463	0.00771	CcSEcCtD
Norepinephrine—Bradycardia—Dorzolamide—glaucoma	0.000452	0.00753	CcSEcCtD
Norepinephrine—Bradycardia—Travoprost—glaucoma	0.00045	0.0075	CcSEcCtD
Norepinephrine—Sweating—Pilocarpine—glaucoma	0.000448	0.00747	CcSEcCtD
Norepinephrine—Photophobia—Timolol—glaucoma	0.000446	0.00743	CcSEcCtD
Norepinephrine—Bradycardia—Brinzolamide—glaucoma	0.000444	0.00741	CcSEcCtD
Norepinephrine—Dyspnoea—Latanoprost—glaucoma	0.000429	0.00715	CcSEcCtD
Norepinephrine—Bradycardia—Pilocarpine—glaucoma	0.000427	0.00712	CcSEcCtD
Norepinephrine—Arrhythmia—Brimonidine—glaucoma	0.000415	0.00692	CcSEcCtD
Norepinephrine—Chest pain—Apraclonidine—glaucoma	0.000401	0.00669	CcSEcCtD
Norepinephrine—Arrhythmia—Dorzolamide—glaucoma	0.000397	0.00661	CcSEcCtD
Norepinephrine—Hypertension—Bimatoprost—glaucoma	0.000395	0.00658	CcSEcCtD
Norepinephrine—Arrhythmia—Brinzolamide—glaucoma	0.00039	0.0065	CcSEcCtD
Norepinephrine—Chest pain—Bimatoprost—glaucoma	0.000389	0.00649	CcSEcCtD
Norepinephrine—Anxiety—Bimatoprost—glaucoma	0.000388	0.00646	CcSEcCtD
Norepinephrine—Arrhythmia—Pilocarpine—glaucoma	0.000375	0.00625	CcSEcCtD
Norepinephrine—Headache—Metipranolol—glaucoma	0.000371	0.00619	CcSEcCtD
Norepinephrine—Sweating—Clonidine—glaucoma	0.000358	0.00596	CcSEcCtD
Norepinephrine—Hypertension—Brimonidine—glaucoma	0.00035	0.00582	CcSEcCtD
Norepinephrine—Chest pain—Brimonidine—glaucoma	0.000345	0.00574	CcSEcCtD
Norepinephrine—Headache—Carteolol—glaucoma	0.000344	0.00574	CcSEcCtD
Norepinephrine—Anxiety—Brimonidine—glaucoma	0.000343	0.00572	CcSEcCtD
Norepinephrine—Vomiting—Diclofenamide—glaucoma	0.000343	0.00572	CcSEcCtD
Norepinephrine—Dyspnoea—Apraclonidine—glaucoma	0.000343	0.00572	CcSEcCtD
Norepinephrine—Bradycardia—Clonidine—glaucoma	0.000341	0.00569	CcSEcCtD
Norepinephrine—Headache—Diclofenamide—glaucoma	0.000338	0.00564	CcSEcCtD
Norepinephrine—Vomiting—Carbachol—glaucoma	0.000335	0.00559	CcSEcCtD
Norepinephrine—Hypertension—Dorzolamide—glaucoma	0.000334	0.00556	CcSEcCtD
Norepinephrine—Dyspnoea—Bimatoprost—glaucoma	0.000333	0.00554	CcSEcCtD
Norepinephrine—Hypertension—Travoprost—glaucoma	0.000332	0.00554	CcSEcCtD
Norepinephrine—Headache—Carbachol—glaucoma	0.00033	0.0055	CcSEcCtD
Norepinephrine—Chest pain—Dorzolamide—glaucoma	0.000329	0.00549	CcSEcCtD
Norepinephrine—Hypertension—Brinzolamide—glaucoma	0.000328	0.00547	CcSEcCtD
Norepinephrine—Anxiety—Dorzolamide—glaucoma	0.000328	0.00547	CcSEcCtD
Norepinephrine—Chest pain—Travoprost—glaucoma	0.000328	0.00546	CcSEcCtD
Norepinephrine—Anxiety—Travoprost—glaucoma	0.000327	0.00544	CcSEcCtD
Norepinephrine—Headache—Levobunolol—glaucoma	0.000325	0.00542	CcSEcCtD
Norepinephrine—Chest pain—Brinzolamide—glaucoma	0.000324	0.00539	CcSEcCtD
Norepinephrine—Vomiting—Methazolamide—glaucoma	0.000316	0.00527	CcSEcCtD
Norepinephrine—Hypertension—Pilocarpine—glaucoma	0.000315	0.00526	CcSEcCtD
Norepinephrine—Sweating—Betaxolol—glaucoma	0.000312	0.00519	CcSEcCtD
Norepinephrine—Headache—Methazolamide—glaucoma	0.000312	0.00519	CcSEcCtD
Norepinephrine—Chest pain—Pilocarpine—glaucoma	0.000311	0.00518	CcSEcCtD
Norepinephrine—Anxiety—Pilocarpine—glaucoma	0.00031	0.00517	CcSEcCtD
Norepinephrine—Hyperhidrosis—Dorzolamide—glaucoma	0.000305	0.00508	CcSEcCtD
Norepinephrine—Headache—Latanoprost—glaucoma	0.000302	0.00503	CcSEcCtD
Norepinephrine—Arrhythmia—Clonidine—glaucoma	0.000299	0.00499	CcSEcCtD
Norepinephrine—Bradycardia—Betaxolol—glaucoma	0.000297	0.00495	CcSEcCtD
Norepinephrine—Dyspnoea—Brimonidine—glaucoma	0.000295	0.00491	CcSEcCtD
Norepinephrine—Hyperhidrosis—Pilocarpine—glaucoma	0.000288	0.0048	CcSEcCtD
Norepinephrine—Dyspnoea—Dorzolamide—glaucoma	0.000281	0.00469	CcSEcCtD
Norepinephrine—Dyspnoea—Travoprost—glaucoma	0.00028	0.00467	CcSEcCtD
Norepinephrine—Dyspnoea—Brinzolamide—glaucoma	0.000277	0.00461	CcSEcCtD
Norepinephrine—Dyspnoea—Pilocarpine—glaucoma	0.000266	0.00443	CcSEcCtD
Norepinephrine—Arrhythmia—Betaxolol—glaucoma	0.000261	0.00434	CcSEcCtD
Norepinephrine—Sweating—Timolol—glaucoma	0.000255	0.00424	CcSEcCtD
Norepinephrine—Chest pain—Clonidine—glaucoma	0.000248	0.00414	CcSEcCtD
Norepinephrine—Anxiety—Clonidine—glaucoma	0.000248	0.00412	CcSEcCtD
Norepinephrine—Vomiting—Apraclonidine—glaucoma	0.000245	0.00408	CcSEcCtD
Norepinephrine—Bradycardia—Timolol—glaucoma	0.000243	0.00404	CcSEcCtD
Norepinephrine—Headache—Apraclonidine—glaucoma	0.000241	0.00402	CcSEcCtD
Norepinephrine—Headache—Bimatoprost—glaucoma	0.000234	0.0039	CcSEcCtD
Norepinephrine—Hyperhidrosis—Clonidine—glaucoma	0.00023	0.00384	CcSEcCtD
Norepinephrine—Vomiting—Acetazolamide—glaucoma	0.000219	0.00365	CcSEcCtD
Norepinephrine—Chest pain—Betaxolol—glaucoma	0.000216	0.0036	CcSEcCtD
Norepinephrine—Headache—Acetazolamide—glaucoma	0.000216	0.00359	CcSEcCtD
Norepinephrine—Anxiety—Betaxolol—glaucoma	0.000215	0.00359	CcSEcCtD
Norepinephrine—Arrhythmia—Timolol—glaucoma	0.000213	0.00355	CcSEcCtD
Norepinephrine—Dyspnoea—Clonidine—glaucoma	0.000212	0.00354	CcSEcCtD
Norepinephrine—Headache—Brimonidine—glaucoma	0.000207	0.00345	CcSEcCtD
Norepinephrine—Vomiting—Dorzolamide—glaucoma	0.000201	0.00334	CcSEcCtD
Norepinephrine—Hyperhidrosis—Betaxolol—glaucoma	0.0002	0.00334	CcSEcCtD
Norepinephrine—Headache—Dorzolamide—glaucoma	0.000198	0.00329	CcSEcCtD
Norepinephrine—Vomiting—Brinzolamide—glaucoma	0.000197	0.00329	CcSEcCtD
Norepinephrine—Headache—Travoprost—glaucoma	0.000197	0.00328	CcSEcCtD
Norepinephrine—Headache—Brinzolamide—glaucoma	0.000194	0.00324	CcSEcCtD
Norepinephrine—Vomiting—Pilocarpine—glaucoma	0.00019	0.00316	CcSEcCtD
Norepinephrine—Headache—Pilocarpine—glaucoma	0.000187	0.00311	CcSEcCtD
Norepinephrine—Dyspnoea—Betaxolol—glaucoma	0.000185	0.00308	CcSEcCtD
Norepinephrine—Hypertension—Timolol—glaucoma	0.000179	0.00299	CcSEcCtD
Norepinephrine—Chest pain—Timolol—glaucoma	0.000177	0.00294	CcSEcCtD
Norepinephrine—Anxiety—Timolol—glaucoma	0.000176	0.00293	CcSEcCtD
Norepinephrine—Hyperhidrosis—Timolol—glaucoma	0.000164	0.00273	CcSEcCtD
Norepinephrine—Vomiting—Clonidine—glaucoma	0.000151	0.00252	CcSEcCtD
Norepinephrine—Dyspnoea—Timolol—glaucoma	0.000151	0.00252	CcSEcCtD
Norepinephrine—Headache—Clonidine—glaucoma	0.000149	0.00249	CcSEcCtD
Norepinephrine—Vomiting—Betaxolol—glaucoma	0.000132	0.0022	CcSEcCtD
Norepinephrine—Headache—Betaxolol—glaucoma	0.00013	0.00216	CcSEcCtD
Norepinephrine—Vomiting—Timolol—glaucoma	0.000108	0.00179	CcSEcCtD
Norepinephrine—Headache—Timolol—glaucoma	0.000106	0.00177	CcSEcCtD
Norepinephrine—ADRB2—GPCR downstream signaling—C3—glaucoma	7.74e-06	0.000158	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—MTHFR—glaucoma	7.71e-06	0.000158	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—HDAC9—glaucoma	7.62e-06	0.000156	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—EDN1—glaucoma	7.62e-06	0.000156	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—EDN1—glaucoma	7.61e-06	0.000156	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—NGF—glaucoma	7.53e-06	0.000154	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—EDN1—glaucoma	7.5e-06	0.000153	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CA1—glaucoma	7.49e-06	0.000153	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—NTRK2—glaucoma	7.4e-06	0.000151	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—SMO—glaucoma	7.37e-06	0.000151	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—EDN1—glaucoma	7.33e-06	0.00015	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—C3—glaucoma	7.33e-06	0.00015	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—SMO—glaucoma	7.31e-06	0.000149	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CTSA—glaucoma	7.26e-06	0.000148	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—SMO—glaucoma	7.21e-06	0.000147	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—C3—glaucoma	7.21e-06	0.000147	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—C3—glaucoma	7.19e-06	0.000147	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—APOE—glaucoma	7.17e-06	0.000147	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—C3—glaucoma	7.16e-06	0.000146	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—C3—glaucoma	7.12e-06	0.000146	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—CAV1—glaucoma	7.11e-06	0.000145	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—HDAC9—glaucoma	7.08e-06	0.000145	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—C3—glaucoma	7.03e-06	0.000144	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—EDN1—glaucoma	6.91e-06	0.000141	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CA2—glaucoma	6.85e-06	0.00014	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—CYP1B1—glaucoma	6.84e-06	0.00014	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—ABCA1—glaucoma	6.84e-06	0.00014	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—SMO—glaucoma	6.83e-06	0.00014	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—EDN1—glaucoma	6.81e-06	0.000139	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—GSTT1—glaucoma	6.78e-06	0.000139	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—NTRK2—glaucoma	6.74e-06	0.000138	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—SMO—glaucoma	6.72e-06	0.000137	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.7e-06	0.000137	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.7e-06	0.000137	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—NTRK2—glaucoma	6.68e-06	0.000137	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—APOE—glaucoma	6.66e-06	0.000136	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—EDN1—glaucoma	6.66e-06	0.000136	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—C3—glaucoma	6.65e-06	0.000136	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—ABCA1—glaucoma	6.65e-06	0.000136	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—CYP1B1—glaucoma	6.65e-06	0.000136	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—C3—glaucoma	6.65e-06	0.000136	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—CAV1—glaucoma	6.6e-06	0.000135	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—NTRK2—glaucoma	6.6e-06	0.000135	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—NOS3—glaucoma	6.57e-06	0.000134	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—C3—glaucoma	6.55e-06	0.000134	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—C3—glaucoma	6.41e-06	0.000131	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—ABCA1—glaucoma	6.38e-06	0.00013	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—CYP1B1—glaucoma	6.38e-06	0.00013	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—NGFR—glaucoma	6.35e-06	0.00013	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—FN1—glaucoma	6.28e-06	0.000128	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—NTRK2—glaucoma	6.24e-06	0.000128	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—VEGFA—glaucoma	6.24e-06	0.000128	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—BAD—glaucoma	6.21e-06	0.000127	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—SMO—glaucoma	6.19e-06	0.000127	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—EDN1—glaucoma	6.19e-06	0.000126	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—NTRK2—glaucoma	6.14e-06	0.000126	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—C3—glaucoma	6.04e-06	0.000123	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—NTRK1—glaucoma	6.03e-06	0.000123	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—SMO—glaucoma	5.97e-06	0.000122	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—C3—glaucoma	5.95e-06	0.000122	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—VEGFA—glaucoma	5.83e-06	0.000119	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—C3—glaucoma	5.82e-06	0.000119	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—NGFR—glaucoma	5.79e-06	0.000118	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—NGFR—glaucoma	5.73e-06	0.000117	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NTRK2—glaucoma	5.66e-06	0.000116	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—NGFR—glaucoma	5.66e-06	0.000116	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CDKN2B—glaucoma	5.56e-06	0.000114	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SMO—glaucoma	5.54e-06	0.000113	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—NTRK1—glaucoma	5.5e-06	0.000112	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—GSTM1—glaucoma	5.47e-06	0.000112	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NTRK2—glaucoma	5.46e-06	0.000112	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—NTRK1—glaucoma	5.45e-06	0.000111	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—C3—glaucoma	5.41e-06	0.00011	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—ABCA1—glaucoma	5.4e-06	0.00011	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—CYP1B1—glaucoma	5.4e-06	0.00011	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—NTRK1—glaucoma	5.38e-06	0.00011	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—NOS3—glaucoma	5.37e-06	0.00011	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—NGFR—glaucoma	5.36e-06	0.000109	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—EDN1—glaucoma	5.34e-06	0.000109	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—GSTM1—glaucoma	5.32e-06	0.000109	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—NGFR—glaucoma	5.27e-06	0.000108	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—GSTM1—glaucoma	5.1e-06	0.000104	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—NTRK1—glaucoma	5.09e-06	0.000104	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NTRK2—glaucoma	5.07e-06	0.000104	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CDKN2B—glaucoma	5.07e-06	0.000104	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CDKN2B—glaucoma	5.02e-06	0.000103	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—NTRK1—glaucoma	5.01e-06	0.000102	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—NOS3—glaucoma	4.99e-06	0.000102	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CDKN2B—glaucoma	4.96e-06	0.000101	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—PTGS2—glaucoma	4.92e-06	0.0001	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—NGF—glaucoma	4.9e-06	0.0001	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—EDN1—glaucoma	4.86e-06	9.94e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NGFR—glaucoma	4.86e-06	9.93e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—MTHFR—glaucoma	4.83e-06	9.88e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—TXN—glaucoma	4.83e-06	9.87e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—EDN1—glaucoma	4.82e-06	9.85e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—EDN1—glaucoma	4.76e-06	9.72e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—VEGFA—glaucoma	4.73e-06	9.67e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—TP53—glaucoma	4.71e-06	9.63e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—MTHFR—glaucoma	4.7e-06	9.61e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CDKN2B—glaucoma	4.69e-06	9.59e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NGFR—glaucoma	4.68e-06	9.57e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—C3—glaucoma	4.66e-06	9.53e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NTRK1—glaucoma	4.62e-06	9.44e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CDKN2B—glaucoma	4.62e-06	9.43e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—MTHFR—glaucoma	4.51e-06	9.21e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—EDN1—glaucoma	4.5e-06	9.2e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—APOE—glaucoma	4.5e-06	9.2e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—NGF—glaucoma	4.47e-06	9.13e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—CAV1—glaucoma	4.46e-06	9.11e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NTRK1—glaucoma	4.45e-06	9.09e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—EDN1—glaucoma	4.43e-06	9.05e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—NGF—glaucoma	4.43e-06	9.05e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.41e-06	9.01e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—TP53—glaucoma	4.4e-06	9e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—APOE—glaucoma	4.38e-06	8.95e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—NGF—glaucoma	4.37e-06	8.93e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.37e-06	8.92e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NGFR—glaucoma	4.35e-06	8.89e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—APOE—glaucoma	4.34e-06	8.87e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—CAV1—glaucoma	4.34e-06	8.86e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—CDKN1B—glaucoma	4.32e-06	8.84e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—GSTM1—glaucoma	4.32e-06	8.83e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CAV1—glaucoma	4.3e-06	8.79e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CDKN2B—glaucoma	4.26e-06	8.7e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—C3—glaucoma	4.25e-06	8.68e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—C3—glaucoma	4.21e-06	8.6e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—APOE—glaucoma	4.19e-06	8.57e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—CAV1—glaucoma	4.16e-06	8.49e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—C3—glaucoma	4.15e-06	8.49e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—NGF—glaucoma	4.14e-06	8.45e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NTRK1—glaucoma	4.13e-06	8.45e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CDKN2B—glaucoma	4.1e-06	8.38e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—FN1—glaucoma	4.09e-06	8.37e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—EDN1—glaucoma	4.08e-06	8.35e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—NGF—glaucoma	4.07e-06	8.32e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—BAD—glaucoma	4.04e-06	8.27e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—MMP9—glaucoma	4e-06	8.19e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—APOE—glaucoma	3.95e-06	8.08e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—EDN1—glaucoma	3.93e-06	8.04e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—C3—glaucoma	3.93e-06	8.04e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—APOE—glaucoma	3.92e-06	8.01e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CAV1—glaucoma	3.92e-06	8.01e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CAV1—glaucoma	3.88e-06	7.94e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—C3—glaucoma	3.87e-06	7.91e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—APOE—glaucoma	3.87e-06	7.91e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CAV1—glaucoma	3.83e-06	7.83e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—MTHFR—glaucoma	3.82e-06	7.81e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CDKN2B—glaucoma	3.81e-06	7.79e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NGF—glaucoma	3.75e-06	7.67e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GSTT1—glaucoma	3.74e-06	7.65e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—FN1—glaucoma	3.73e-06	7.62e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—FN1—glaucoma	3.69e-06	7.55e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—BAD—glaucoma	3.68e-06	7.53e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—APOE—glaucoma	3.66e-06	7.48e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—EDN1—glaucoma	3.66e-06	7.47e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—BAD—glaucoma	3.65e-06	7.46e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—FN1—glaucoma	3.65e-06	7.46e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CAV1—glaucoma	3.63e-06	7.41e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NGF—glaucoma	3.61e-06	7.39e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—BAD—glaucoma	3.6e-06	7.37e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—APOE—glaucoma	3.6e-06	7.36e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—VEGFA—glaucoma	3.6e-06	7.35e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—TP53—glaucoma	3.58e-06	7.31e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CAV1—glaucoma	3.57e-06	7.29e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—C3—glaucoma	3.57e-06	7.29e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—APOE—glaucoma	3.55e-06	7.27e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—CAV1—glaucoma	3.52e-06	7.2e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—FN1—glaucoma	3.45e-06	7.06e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—C3—glaucoma	3.44e-06	7.02e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—BAD—glaucoma	3.41e-06	6.97e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—FN1—glaucoma	3.4e-06	6.94e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—NOS3—glaucoma	3.37e-06	6.89e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NGF—glaucoma	3.36e-06	6.87e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—BAD—glaucoma	3.36e-06	6.86e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—APOE—glaucoma	3.32e-06	6.79e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CAV1—glaucoma	3.29e-06	6.73e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—NOS3—glaucoma	3.28e-06	6.7e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—NOS3—glaucoma	3.25e-06	6.65e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—APOE—glaucoma	3.2e-06	6.54e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—C3—glaucoma	3.19e-06	6.53e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CAV1—glaucoma	3.17e-06	6.48e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—NOS3—glaucoma	3.14e-06	6.42e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—FN1—glaucoma	3.13e-06	6.4e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—BAD—glaucoma	3.09e-06	6.33e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—PTGS2—glaucoma	3.08e-06	6.3e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.02e-06	6.17e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—FN1—glaucoma	3.02e-06	6.17e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—PTGS2—glaucoma	3e-06	6.13e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ABCA1—glaucoma	2.98e-06	6.1e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CYP1B1—glaucoma	2.98e-06	6.1e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—BAD—glaucoma	2.98e-06	6.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—APOE—glaucoma	2.97e-06	6.08e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—NOS3—glaucoma	2.96e-06	6.06e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CAV1—glaucoma	2.95e-06	6.02e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—NOS3—glaucoma	2.94e-06	6e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—NOS3—glaucoma	2.9e-06	5.92e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—PTGS2—glaucoma	2.87e-06	5.87e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CDKN1B—glaucoma	2.82e-06	5.76e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—FN1—glaucoma	2.8e-06	5.73e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—BAD—glaucoma	2.77e-06	5.66e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—NOS3—glaucoma	2.74e-06	5.6e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—TP53—glaucoma	2.72e-06	5.55e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—NOS3—glaucoma	2.7e-06	5.52e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—NOS3—glaucoma	2.66e-06	5.44e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MMP9—glaucoma	2.61e-06	5.33e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CDKN1B—glaucoma	2.57e-06	5.25e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CDKN1B—glaucoma	2.54e-06	5.2e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CDKN1B—glaucoma	2.51e-06	5.13e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NOS3—glaucoma	2.49e-06	5.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PTGS2—glaucoma	2.44e-06	4.98e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NOS3—glaucoma	2.4e-06	4.9e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GSTM1—glaucoma	2.39e-06	4.88e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MMP9—glaucoma	2.38e-06	4.86e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CDKN1B—glaucoma	2.38e-06	4.86e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MMP9—glaucoma	2.35e-06	4.81e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—VEGFA—glaucoma	2.34e-06	4.79e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CDKN1B—glaucoma	2.34e-06	4.78e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MMP9—glaucoma	2.32e-06	4.75e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NOS3—glaucoma	2.23e-06	4.55e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MMP9—glaucoma	2.2e-06	4.5e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MMP9—glaucoma	2.16e-06	4.43e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CDKN1B—glaucoma	2.16e-06	4.41e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—VEGFA—glaucoma	2.13e-06	4.36e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—VEGFA—glaucoma	2.11e-06	4.32e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—MTHFR—glaucoma	2.11e-06	4.31e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—VEGFA—glaucoma	2.09e-06	4.27e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CDKN1B—glaucoma	2.08e-06	4.24e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MMP9—glaucoma	2e-06	4.08e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—VEGFA—glaucoma	1.98e-06	4.04e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—APOE—glaucoma	1.96e-06	4.01e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CAV1—glaucoma	1.94e-06	3.97e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—VEGFA—glaucoma	1.94e-06	3.97e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CDKN1B—glaucoma	1.93e-06	3.94e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MMP9—glaucoma	1.92e-06	3.93e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—VEGFA—glaucoma	1.79e-06	3.66e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MMP9—glaucoma	1.79e-06	3.65e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TP53—glaucoma	1.77e-06	3.62e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—VEGFA—glaucoma	1.73e-06	3.53e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TP53—glaucoma	1.61e-06	3.3e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—VEGFA—glaucoma	1.6e-06	3.28e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TP53—glaucoma	1.6e-06	3.27e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TP53—glaucoma	1.58e-06	3.22e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TP53—glaucoma	1.49e-06	3.05e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—NOS3—glaucoma	1.47e-06	3.01e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TP53—glaucoma	1.47e-06	3e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TP53—glaucoma	1.35e-06	2.77e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PTGS2—glaucoma	1.34e-06	2.75e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TP53—glaucoma	1.3e-06	2.67e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TP53—glaucoma	1.21e-06	2.48e-05	CbGpPWpGaD
